Legend Biotech appoints Carlos Santos as CFO

[concept word CFO on cubes.close up of wooden elements,Business Concept.3D rendering on blue background.]

Legend Biotech (NASDAQ:LEGN [https://seekingalpha.com/symbol/LEGN]) has appointed [https://seekingalpha.com/pr/20203488-legend-biotech-appoints-carlos-santos-as-chief-financial-officer] Carlos Santos as its new CFO, effective immediately. He takes over from Jessie Yeung, who had been the interim CFO since January.

Santos is a seasoned finance executive with leadership experience in the pharmaceutical and technology sectors across the Americas, Europe, the Middle East, and Africa.

Prior to joining Legend Biotech, Santos was CFO for US Oncology at AstraZeneca.

MORE ON LEGEND BIOTECH

* Legend Biotech: Q2 Record Sales Undermined By Losses, Immature Pipeline - Rating Downgrade [https://seekingalpha.com/article/4813740-legend-biotech-q2-record-sales-undermined-by-losses-immature-pipeline-rating-downgrade]
* Legend Biotech Corporation 2025 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4812270-legend-biotech-corporation-2025-q2-results-earnings-call-presentation]
* Legend Biotech Corporation (LEGN) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4812269-legend-biotech-corporation-legn-q2-2025-earnings-call-transcript]
* SA Asks: Which oncology companies are attractive M&A targets? [https://seekingalpha.com/news/4452742-sa-asks-which-oncology-companies-are-attractive-ma-targets]
* Seeking Alpha’s Quant Rating on Legend Biotech [https://seekingalpha.com/symbol/LEGN/ratings/quant-ratings]